Sanam Innovation Holding Acquires 75% Stake in NATMED

Deal News | Dec 23, 2024 | Legal Community MENA

Sanam Innovation Holding Acquires 75% Stake in NATMED

In a significant strategic transaction, Sanam Innovation Holding Company (SIHC) and Arzan Financial Group for Financing and Investment have successfully acquired a 75% stake in NATMED, a move valued at approximately $33 million. Meysan, a prominent legal advisory firm, played a critical role in facilitating this acquisition, acting as legal advisors to the buying consortium. The deal demonstrates the strategic synergies between SIHC and Arzan as they expand their footprint in the healthcare industry through this substantial acquisition. The transaction exemplifies the growing trend of regional investment groups teaming up to leverage combined strategic and financial strengths for extensive market impact.

Sectors

  • Healthcare
  • Financial Services
  • Legal Services

Geography

  • Middle East – Reflects the regional concentration of the entities involved, including Meysan and the acquiring companies.

Industry

  • Healthcare – NATMED’s primary industry, indicating the healthcare sector's significance behind the acquisition.
  • Financial Services – Arzan Financial Group’s involvement highlights the relevance of financial services in structuring the deal.
  • Legal Services – Meysan’s role as legal advisor emphasizes the importance of legal services in facilitating mergers and acquisitions.

Financials

  • 33000000 – The transaction value of the 75% acquisition of NATMED by Sanam Innovation Holding and Arzan Financial Group.

Participants

NameRoleTypeDescription
NATMEDTargetCompanyThe company being acquired with a 75% stake involved in the healthcare sector.
Sanam Innovation Holding CompanyBuyerCompanyOne of the buying firms in the acquisition of NATMED, focusing on strategic growth.
Arzan Financial Group for Financing and InvestmentBuyerCompanyA financial group involved in financing the acquisition of NATMED.
MeysanLegal AdvisorCompanyProvided legal advisory services to the buying consortium in the acquisition.